Exploiting gold nanoparticle as a probe to identify therapeutic targets
利用金纳米颗粒作为探针来识别治疗靶点
基本信息
- 批准号:10540753
- 负责人:
- 金额:$ 38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-12-15 至 2026-11-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdsorptionAngiogenesis InhibitionAnimal ModelBindingBiodistributionBioinformaticsBiologicalBiological ModelsBiological ProcessCellsCisplatinCoupledDataDatabasesDiabetic RetinopathyDiseaseDisease OutcomeDrug resistanceEpitheliumExposure toFibroblastsGoldHeparin Binding Growth FactorHumanIn VitroIncubatedInterventionLiquid substanceMAP Kinase GeneMacular degenerationMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of ovaryMalignant neoplasm of pancreasMass Spectrum AnalysisMesenchymalMethodologyModelingMolecular ConformationNeoplasm MetastasisNodalNormal CellPatientsPlasmaProcessPropertyProtein ConformationProteinsReportingResistanceRheumatoid ArthritisSchemeSequence HomologySeriesSignal TransductionSmall Interfering RNASurfaceTestingTherapeuticTissuesToxic effectTreatment EfficacyTumor PromotionTumor TissueValidationcancer cellclinically significantdelivery vehicledrug-sensitiveexperimental studyin vivoinhibitor therapyinsightliposomal deliverynanoGoldnanoparticlenanotoxicitynovelovarian neoplasmpancreatic cancer modelpersonalized medicineprotein distributionprotein functionresponsesiRNA deliverysmall molecule inhibitortherapeutic nanoparticlestherapeutic targettumor growthtumor microenvironment
项目摘要
Nanoparticles (NPs) have mostly been used as delivery vehicles for various biomedical applications. When
exposed to biological fluids NPs interact with proteins forming a biological coating on their surface, termed protein
corona. Protein corona around NPs have been investigated to address the biological responses including
biodistribution, clearance and potential toxicity of NP. Previously, we along with others have demonstrated self-
therapeutic property of gold nanoparticles (GNPs). In the current application, exploiting self-therapeutic GNP
(ST-GNP) as a probe, we are proposing a unique concept of capturing, identifying and validating therapeutic
targets responsible for tumor growth and therapy resistance in cancer.
We demonstrated that ST-GNP inhibited functions of a number of tumor-promoting heparin-binding
growth factors (HB-GFs) via binding through the HB-domain that altered protein conformations, whereas
conformations and functions of non-HB-GFs remained unaltered. In addition, among various sizes, GNP of 20
nm size demonstrated highest therapeutic efficacy whereas GNP of 100 nm size was non self-therapeutic (NST-
GNP). Importantly, ST-GNP inhibited tumor growth, metastasis and sensitized ovarian cancer cells to cisplatin
by reversing epithelial-mesenchymal transition (EMT) and abrogating MAPK-signaling (Fig 1) In orthotopic
model of pancreatic cancer, we reported that ST-GNP disrupted cross-talk between cancer cells and cancer
associated fibroblasts (CAFs) and reprogrammed tumor microenvironment that inhibited tumor growth.
Investigating protein enrichment on ST-GNP from ovarian cancer or normal cellular lysates, we identified
SMNDC1 and PPA1, as potential new targets for tumor growth. Furthermore, we recently reported that non-toxic
Auroliposome enhanced silencing efficacy of siRNA and more effectively inhibited ovarian tumor growth
compared to traditional DOTAP-DOPE based liposomal delivery of siRNA. Based on these results, we
hypothesize that functions of the proteins enriched on ST-GNP will be inhibited resulting in tumor growth
inhibition and therapy resistance. Therefore, these ST-GNP-enriched proteins may serve as potential therapeutic
targets. We will use specific aims below to test our hypothesis;
Specific aim 1: Investigating protein enrichment on ST-GNP.
Specific aim 2: Validating therapeutic targets in animal models.
Impact: Protein corona around NPs is evolving as a unique signature for personalized medicine. Our findings
support that the ST-GNP could be utilized to identify therapeutic targets not only for ovarian and pancreatic
cancer but in diabetic retinopathy, macular degeneration and rheumatoid arthritis as well where others have
reported ST property of GNP to inhibit angiogenesis in these models.
纳米颗粒(NPs)主要用作各种生物医学应用的递送载体。当
暴露于生物流体的NP与蛋白质相互作用,在其表面上形成生物涂层,称为蛋白质
电晕。已经研究了NP周围的蛋白质冠,以解决生物反应,包括
NP的生物分布、清除率和潜在毒性。以前,我们沿着与别人展示自我-
金纳米颗粒(GNP)的治疗特性。在当前的应用中,开发自我治疗GNP
(ST-GNP)作为探针,我们提出了一个独特的概念,捕获,识别和验证治疗
靶点负责肿瘤生长和癌症的治疗抗性。
我们证明ST-GNP抑制了许多促进肿瘤的肝素结合功能
生长因子(HB-GFs)通过HB结构域结合改变蛋白质构象,而
非HB-GF的构象和功能保持不变。此外,在各种规模中,GNP为20
纳米尺寸的GNP显示出最高的治疗功效,而100纳米尺寸的GNP是非自我治疗的(NST-100)。
GNP)。重要的是,ST-GNP抑制肿瘤生长、转移和对顺铂敏感的卵巢癌细胞
通过逆转上皮-间充质转化(EMT)和废除MAPK信号传导(图1),
在胰腺癌模型中,我们报道了ST-GNP破坏了癌细胞和癌细胞之间的相互作用,
相关的成纤维细胞(CAF)和抑制肿瘤生长的重编程肿瘤微环境。
通过研究卵巢癌或正常细胞裂解物中ST-GNP的蛋白富集,我们发现
SMNDC 1和PPA 1是肿瘤生长的潜在新靶点。此外,我们最近报告说,无毒
金脂质体增强siRNA沉默效果,更有效地抑制卵巢肿瘤生长
与传统的基于DOTAP-DOPE的siRNA脂质体递送相比。基于这些结果,我们
假设ST-GNP上富集的蛋白质的功能将被抑制,导致肿瘤生长
抑制和治疗抗性。因此,这些富含ST-GNP的蛋白质可作为潜在的治疗剂。
目标的我们将使用下面的具体目标来测试我们的假设;
具体目标1:研究ST-GNP上的蛋白富集。
具体目标2:在动物模型中验证治疗靶点。
影响:NP周围的蛋白质冠正在演变为个性化医疗的独特特征。我们的研究结果
支持ST-GNP不仅可用于确定卵巢和胰腺癌的治疗靶点,
糖尿病性视网膜病变、黄斑变性和类风湿性关节炎,
报道了在这些模型中GNP抑制血管生成的ST性质。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Resham Bhattacharya其他文献
Resham Bhattacharya的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Resham Bhattacharya', 18)}}的其他基金
Exploiting gold nanoparticle as a probe to identify therapeutic targets
利用金纳米颗粒作为探针来识别治疗靶点
- 批准号:
10374481 - 财政年份:2021
- 资助金额:
$ 38万 - 项目类别:
Normalizing aberrant metabolism in ovarian cancer by a unique drug delivery system
通过独特的药物输送系统使卵巢癌的异常代谢正常化
- 批准号:
10323273 - 财政年份:2021
- 资助金额:
$ 38万 - 项目类别:
Normalizing aberrant metabolism in ovarian cancer by a unique drug delivery system
通过独特的药物输送系统使卵巢癌的异常代谢正常化
- 批准号:
10545752 - 财政年份:2021
- 资助金额:
$ 38万 - 项目类别:
Cystathionine beta synthase (CBS) and angiogenesis
胱硫醚β合酶 (CBS) 和血管生成
- 批准号:
9276099 - 财政年份:2013
- 资助金额:
$ 38万 - 项目类别:
Cystathionine beta synthase (CBS) and angiogenesis
胱硫醚β合酶 (CBS) 和血管生成
- 批准号:
8722024 - 财政年份:2013
- 资助金额:
$ 38万 - 项目类别:
Cystathionine beta synthase (CBS) and angiogenesis
胱硫醚β合酶 (CBS) 和血管生成
- 批准号:
8598396 - 财政年份:2013
- 资助金额:
$ 38万 - 项目类别:
Cystathionine beta synthase (CBS) and angiogenesis
胱硫醚β合酶 (CBS) 和血管生成
- 批准号:
9086422 - 财政年份:2013
- 资助金额:
$ 38万 - 项目类别:
Cystathionine beta synthase (CBS) and angiogenesis
胱硫醚β合酶 (CBS) 和血管生成
- 批准号:
8877629 - 财政年份:2013
- 资助金额:
$ 38万 - 项目类别:
Bmi-1, a potential therapeutic target in ovarian cancer
Bmi-1,卵巢癌的潜在治疗靶点
- 批准号:
9067819 - 财政年份:2012
- 资助金额:
$ 38万 - 项目类别:
相似海外基金
Molecular Simulations of Additive Self-Assembly, Rheology, and Surface Adsorption in Complex Fluids
复杂流体中添加剂自组装、流变学和表面吸附的分子模拟
- 批准号:
2901619 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Studentship
An Adsorption-Compression Cold Thermal Energy Storage System (ACCESS)
吸附压缩冷热能存储系统(ACCESS)
- 批准号:
EP/W027593/2 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Research Grant
Tuning Precision Fabricated Liquid Crystal Adsorbents - Toward Tailored Adsorption of Per- and Polyfluorinated Alkyl Substances
调整精密制造的液晶吸附剂 - 针对全氟和多氟烷基物质的定制吸附
- 批准号:
24K17729 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Thermal stability of adsorption solar power plants
吸附式太阳能发电厂的热稳定性
- 批准号:
2871817 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Studentship
Computational Studies of Gas Adsorption in Special Nuclear Materials (SNMs).
特殊核材料(SNM)中气体吸附的计算研究。
- 批准号:
2903366 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Studentship
Collaborative Research: Integrated experiments and simulations to understand the mechanism and consequences of polymer adsorption in films and nanocomposites
合作研究:综合实验和模拟来了解薄膜和纳米复合材料中聚合物吸附的机制和后果
- 批准号:
2312325 - 财政年份:2023
- 资助金额:
$ 38万 - 项目类别:
Standard Grant
Metal tolerance and metal adsorption through phycosphere control
通过藻圈控制实现金属耐受性和金属吸附
- 批准号:
23H02303 - 财政年份:2023
- 资助金额:
$ 38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Investigation of adsorption of exosomes on porous materials and regulating the behavior to create separation, purification and preservation techniques
研究外泌体在多孔材料上的吸附并调节行为以创建分离、纯化和保存技术
- 批准号:
23KJ0192 - 财政年份:2023
- 资助金额:
$ 38万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Reflection and adsorption of low energy hydrogen on solid surface
低能氢在固体表面的反射与吸附
- 批准号:
23H01158 - 财政年份:2023
- 资助金额:
$ 38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Super-Resolution Imaging of Surface Adsorption on Single Nanoparticles for Electrochemical Dechlorination
用于电化学脱氯的单个纳米颗粒表面吸附的超分辨率成像
- 批准号:
2303933 - 财政年份:2023
- 资助金额:
$ 38万 - 项目类别:
Standard Grant